Naoki Umeda, MD

Appointed
2016

Education & Fellowships

Fellowship - Academy of Integrative Health & Medicine
Integrative Health & Medicine
San Diego, CA United States
2019

Fellowship - Mayo Clinic
Gastroenterology and Hepatology Neoplasia
Rochester, MN
2010

Fellowship - Mayo Clinic
Transplant Hepatology
Rochester, MN
2009

Fellowship - Musashino Red Cross Hospital
Gastroenterology and Hepatology
Tokyo,
2008

Residency - Tokyo Medical and Dental University
Internal Medicine

2005

Medical Education - Tokyo Medical and Dental University

2003

Additional Training

• Dr. Umeda is board-certified in Internal Medicine, Gastroenterology and Hepatology, and Integrative Medicine in Japan.  His strong points include his wide experience of Integrative Oncology for all types of cancer, knows Japanese healthy food culture such as fermented foods, tofu, or green tea, and that he understands both the advantage and disadvantages of Western and Eastern Medicine.  His aim is to maximize patients' own "power of recovery," and he respects each individual's belief and uniqueness.  Dr. Umeda will tailor the personalized treatment plan not only for cancer patients but also for those with chronic diseases such as gastrointestinal disorders, migraine, mood disorders, and fatigue syndrome. 

Professional Highlights

• Fellowship - Academy of Integrative Health & Medicine
  Integrative Medicine
  San Diego, CA USA
  2019
  
  Fellowship - University of Michigan
  Integrative Oncology Scholar (program)
  Ann Arbor, MI USA
  2019

Certifications

• Integrative Medicine
• Hepatology
• Gastroenterology
• Internal Medicine

Specialty Interests

Integrative Medicine, Integrative Oncology, Internal Medicine, Wellness and Preventive Medicine

See publications for Naoki Umeda, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/10/2024, Dr. Umeda has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.